Showing results (361-370 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|September 1, 1995
Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of lifeA G Awad, T P Hogan, L N Voruganti, et al.International Clinical Psychopharmacology|March 27, 2014
Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trialsAngelo Sambunaris, Carl Gommoll, Changzheng Chen, et al.International Clinical Psychopharmacology|May 13, 2014
Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trialHong Jin Jeon, Maurizio Fava, David Mischoulon, et al.International Clinical Psychopharmacology|April 1, 2014
Effectiveness of long-acting injectable antipsychotics in delusional disorders with nonprominent hallucinations and without hallucinationsAlexandre González-Rodríguez, Oriol Molina-Andreu, Rafael Penadés, et al.International Clinical Psychopharmacology|September 30, 2016
Adverse events in children and adolescents treated with quetiapine: an analysis of adverse drug reaction reports from the Danish Medicines Agency databaseKlaus D Jakobsen, Helle Wallach-Kildemoes, Christina H Bruhn, et al.International Clinical Psychopharmacology|October 15, 2016
Lithium and cognition in those with bipolar disorderAmelia Paterson, Gordon ParkerInternational Clinical Psychopharmacology|April 1, 1989
The new selective D2-dopamine receptor antagonist raclopride--pharmacokinetics, safety and tolerability in healthy malesL Farde, C von Bahr, A Wahlen, et al.International Clinical Psychopharmacology|October 4, 2014
Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatmentTania Marcourakis, Márcio A Bernik, Francisco Lotufo Neto, et al.International Clinical Psychopharmacology|July 25, 2013
Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studiesGeorge I Papakostas, Larry Culpepper, Rana S Fayyad, et al.International Clinical Psychopharmacology|December 5, 2013
Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophreniaFalko Biedermann, W Wolfgang Fleischhacker, Georg Kemmler, et al.Pageof 212